1. LFMD is involved in a class action lawsuit regarding misleading statements. 2. Claims include overstatement of competitive position and financial guidance. 3. Shareholders from May 7 to August 5, 2025, can join the lawsuit. 4. The law firm seeks recovery for shareholders from financial deceit. 5. Deadline for lead plaintiff application is October 25, 2025.
Class action lawsuits often lead to significant stock price declines. Similar cases have historically resulted in investor panic and sell-offs.
The lawsuit highlights serious threats to LFMD's financial integrity and future profitability, raising concerns among investors.
The impact is immediate due to the lawsuit announcement, affecting investor sentiment swiftly.
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ:LFMD).
Shareholders who purchased shares of LFMD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=165519&from=4
CLASS PERIOD: May 7, 2025 to August 5, 2025
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated LifeMD's competitive position; (2) defendants were reckless in raising LifeMD's 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and (3) as a result, defendants' statements about LifeMD's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
DEADLINE: October 25, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=165519&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of LFMD during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is October 25, 2025. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download multimedia:https://www.prnewswire.com/news-releases/lost-money-on-lifemd-inclfmd-join-class-action-suit-seeking-recovery--contact-the-gross-law-firm-302548491.html
SOURCE The Gross Law Firm